Ecstasy pill testing: Harm minimization gone too far?

Addiction

Volumn 96, Issue 8, 2001, Pages 1139-1148

  Winstock, A R ^a   Wolff, K ^a   Ramsey, J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ARTICLE; CONSUMER; DRUG ABUSE; DRUG MANUFACTURE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PILL; STEREOCHEMISTRY;

CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; DRUG CONTAMINATION; HUMANS; MASS SPECTROMETRY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PREDICTIVE VALUE OF TESTS; PRODRUGS; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; STREET DRUGS;

EID: 0034911130     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2001.96811397.x     Document Type: Article

References (46)

1. Psychedelic effects of ketamine in healthy volunteers: Relationship to steady-state plasma concentrations
2. Another PMA related fatality in Adelaide
3. Amphetamine derivative fatalities in South Australia - Is 'Ecstasy' the culprit?
4. Deaths in the first two weeks of maintenance treatment in NSW in 1994: Identifying cases of iatrogenic methadone toxicity
5. MDMA induced hyperthermia: A report of a fatality and review of current therapy
6. Gamma-hydroxybutyrate: An emerging drug of abuse that causes physical dependence
7. Guiding principals of drug demand reduction: An international response
8. Discriminative stimulus properties of hallucinogens and related designer drugs
9. Ecstasy and the dance of death
10. p-Methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent
11. Computer aided retrieval of common-batch members in Leukartart amphetamine profiling
12. Windmills in their minds? Policy and drug research in the Netherlands
13. Pragmatism versus ideology: Dutch drug policy continued
14. Identification of the human cytochromes P450 involved in the oxidative metabolism of 'Ecstasy'-related designer drugs
15. Identification of MPTP as an impurity in 'synthetic heroin' and effect on drug users
16. National survey of syringe exchange schemes in England
17. Diversity of psychopathology associated with use of 3, 4 methylenedioxymethamphetamine ('ecstasy')
18. Pathology of deaths associated with 'Ecstasy' and 'eve' misuse
19. Differences between the mechanism of action of MDMA, MBDB and the classic hallucinogens. Identification of a new therapeutic class: Enactogens
20. Medicinal chemistry and structure-activity relationships of hallucinogens
21. Structure-activity relationships of MDMA-like substances
22. Clinical and toxicological aspects of ecstasy
23. Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users. Disease management
24. Solid-phase extraction for profiling of ecstasy tablets
25. L-dopa potentiation of serotonergic deficits due to a single administration of 3, 4 methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats
26. A fentanyl epidemic in Maryland 1992
27. Colour Tests
28. Aids and injecting drug use in the United Kingdom, 1987-1993: The policy response and the prevention of the epidemic
29. The role of endogenous dopamine in the central serotonergic deficits induced by 3, 4-methylenedioxymethamphetamine
30. The demethylation of methylenedioxymethamphetamine (ecstasy) by desbrisoquine hydroxylase (CYP2D6)
31. PMA (paramethoxyamphetamine) as a contaminant of ecstasy tablets
32. Saturday night fever': Ecstasy related problems in a London accident and emergency department
33. Chronic paranoid psychosis after misuse of 3, 4 methylenedioxy methamphetamine
34. Tablets often contain substances in addition to, or instead of ecstasy
35. Drugs and the dance music scene: A survey of current drug use patterns among a sample of dance music enthusiasts in the UK
36. Contents of ecstasy
37. WHO Expert Commitee on Drug Dependence